Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 21
- +1 vs. Q1 2022
- Portfolio value
- $312.4M
- −$40.1M (−11.4%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PCVXVaxcyte, Inc. | COM | 4,168,718 | $90.7M | 29.0% | 00.0% | Unchanged | History |
| SRRASierra Oncology, Inc. | COM | 1,314,127 | $72.3M | 23.1% | +1150.0% | Added | History |
| VERAVera Therapeutics, Inc. | CL A | 2,960,231 | $40.3M | 12.9% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 2,115,385 | $30.9M | 9.9% | 00.0% | Unchanged | History |
| HLVXHilleVax, Inc. | COM | 1,838,486 | $19.9M | 6.4% | +1,838,486 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,435,106 | $12.1M | 3.9% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM | 5,628,558 | $10.6M | 3.4% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,457,500 | $10.2M | 3.3% | +10.0% | Added | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,822,114 | $6.46M | 2.1% | 00.0% | Unchanged | History |
| OKUROnKure Therapeutics, Inc. | COM | 2,073,957 | $5.41M | 1.7% | 00.0% | Unchanged | History |
| SLNOSoleno Therapeutics Inc | COM NEW | 18,022,602 | $3.17M | 1.0% | 00.0% | Unchanged | History |
| Spruce BioE5209E109 | Common | 1,792,518 | $3.10M | 1.0% | 00.0% | Unchanged | – |
| NCNANuCana plc | SPONSORED ADR | 3,333,333 | $2.42M | 0.8% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,041,131 | $2.00M | 0.6% | 00.0% | Unchanged | History |
| SIENProject Sage Oldco, Inc. | COM | 1,673,589 | $1.39M | 0.4% | −676,238−28.8% | Reduced | History |
| XCURExicure, Inc. | COM | 281,636 | $594.0K | 0.2% | +49,069+21.1% | AddedConverted for a 1-for-30 split | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 131,036 | $385.0K | 0.1% | 00.0% | Unchanged | History |
| MTEMMolecular Templates, Inc. | COM | 200,000 | $182.0K | 0.1% | 00.0% | Unchanged | History |
| OBSVObsEva SA | COM | 87,999 | $141.0K | <0.1% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 240,500 | $121.0K | <0.1% | 00.0% | Unchanged | History |
| OCGNOcugen, Inc. | Common | 7,111 | $16.0K | <0.1% | 00.0% | Unchanged | History |